FTHFX | NSGRX | FTHFX / NSGRX | |
Total Expense Ratio | 0.63 | 0.54 | 117% |
Annual Report Gross Expense Ratio | 0.63 | 0.59 | 107% |
Fund Existence | 14 years | 26 years | - |
Gain YTD | 4.535 | -0.316 | -1,435% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 10.7B | 347M | 3,084% |
Annual Yield % from dividends | 0.74 | 1.04 | 71% |
Returns for 1 year | 4.89 | -9.77 | -50% |
Returns for 3 years | 41.50 | 0.40 | 10,448% |
Returns for 5 years | 86.93 | 7.67 | 1,133% |
Returns for 10 years | 151.47 | 24.40 | 621% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRWJX | 27.81 | 0.25 | +0.91% |
MFS Blended Research Growth Eq I | |||
JFNNX | 65.21 | 0.45 | +0.69% |
Janus Henderson Global Life Sciences N | |||
GFFFX | 83.77 | 0.26 | +0.31% |
American Funds Growth Fund of Amer F2 | |||
TMCLX | 8.72 | -0.03 | -0.34% |
Transamerica Energy Infrastructure C | |||
GTDYX | 37.05 | -0.13 | -0.35% |
Invesco EQV Emerging Markets All Cap Y |